Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
April 17, 1992
Amide bond replacements incorporated into CCK-B selective "dipeptoids"
C I Fincham, M Higginbottom, D R Hill, et al.
Biochemical Society Transactions
|
May 22, 2007
The quest for Factor VIIa exosite inhibitors
A Amour, J Hutchinson, A M Ruiz Avendaño, et al.
Neurological Research
|
March 24, 2010
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C Collin, E Ehler, G Waberzinek, et al.
Preventive Oncology & Epidemiology
|
April 27, 2026
Examining implementation strategies to reduce disparities in lung cancer screening uptake by state Medicaid expansion status: a scoping review
Miranda J Reid, Caretia J Washington, Meghann M Wheeler, et al.
Family Medicine
|
May 1, 1992
Teaching family-centered perinatal care in family medicine, Part I
J E Scherger, C Levitt, L S Acheson, et al.
Family Medicine
|
July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2
J E Scherger, C Levitt, L S Acheson, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines
J Charlwood, C Dingwall, R Matico, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 19, 2003
Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces
A F Richards, B Lopman, A Gunn, et al.
Journal of Neonatal-Perinatal Medicine
|
February 1, 2021
Clinical and vital sign changes associated with late-onset sepsis in very low birth weight infants at 3 NICUs
B A Sullivan, V P Nagraj, K L Berry, et al.
European Journal of Neurology
|
March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A Novotna, J Mares, S Ratcliffe, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
April 17, 1992
Amide bond replacements incorporated into CCK-B selective "dipeptoids"
C I Fincham, M Higginbottom, D R Hill, et al.
Biochemical Society Transactions
|
May 22, 2007
The quest for Factor VIIa exosite inhibitors
A Amour, J Hutchinson, A M Ruiz Avendaño, et al.
Neurological Research
|
March 24, 2010
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C Collin, E Ehler, G Waberzinek, et al.
Preventive Oncology & Epidemiology
|
April 27, 2026
Examining implementation strategies to reduce disparities in lung cancer screening uptake by state Medicaid expansion status: a scoping review
Miranda J Reid, Caretia J Washington, Meghann M Wheeler, et al.
Family Medicine
|
May 1, 1992
Teaching family-centered perinatal care in family medicine, Part I
J E Scherger, C Levitt, L S Acheson, et al.
Family Medicine
|
July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2
J E Scherger, C Levitt, L S Acheson, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines
J Charlwood, C Dingwall, R Matico, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 19, 2003
Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces
A F Richards, B Lopman, A Gunn, et al.
Journal of Neonatal-Perinatal Medicine
|
February 1, 2021
Clinical and vital sign changes associated with late-onset sepsis in very low birth weight infants at 3 NICUs
B A Sullivan, V P Nagraj, K L Berry, et al.
European Journal of Neurology
|
March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A Novotna, J Mares, S Ratcliffe, et al.
Page
of 5